7
Braz Dent Sci 2024 July/Sept;27 (3): e4337
Henriques JCG et al.
Recurrent odontogenic k er atocyst and the use of Carnoy’s solution: a case r eport
Henriques JCG et al. Recurrent odontogenic keratocyst and the use of Carnoy’s
solution: a case report
A recurrence rate of 25-30% is reported in the
literature for odontogenic keratocysts, indicating a
high recurrence rate for a cystic lesion. Incomplete
enucleations, usually hindered by a friable cystic
capsule and the potential persistence of small satellite
cysts, would explain these percentages. For this
reason, the treatment of odontogenic keratocysts
involves more aggressive therapies ranging from
enucleations followed by curettage or osteotomies
to surgical resections for larger and more aggressive
lesions [13,14]. It’s worth highlighting the literature
foundation regarding the choice of performing the
decompressive procedure of marsupialization for
larger lesions. Therefore, these lesions not only
respond positively to this decompressive procedure
but also undergo metaplastic transformation of
the epithelium, loss of keratin, and thickening
of the cystic capsule, making the subsequent
enucleation easier due to the dimensional regression
of the lesion [15,16]. In the present case report,
both at the initial diagnosis of the keratocyst
and at the recurrence of the lesion, the patient
underwent marsupialization which responded
favorably, leading to a progressive decrease in the
lesion’s size, despite the patient’s poor cooperation.
The decient hygiene of the lesion cavity resulting
from marsupialization and the patient’s failure to
attend from the second year of follow-up post-
enucleation, underscore how necessary it is for the
team to have frank, enlightening, and sometimes
repetitive dialogue with the adolescent patient and
their family members about the seriousness of the
lesion in question, its high potential for recurrence,
and the undesirable consequences of a potential
disappearance for the future prognosis of the disease.
Especially considering individuals with lower
educational levels and understanding, it falls upon
the involved professionals to have the necessary
sensitivity to perceive whether the communication
was indeed effective and the information about
the continuation of care was properly assimilated.
The case in question seemingly reects some failure
in this professional-patient communication.
Despite the support for treatment through
surgical resections of large keratocysts, the
signicant morbidity for patients undergoing this
therapeutic modality has led many professionals
to opt for enucleation followed by curettage or
osteotomies [12]. And in order to make this more
conservative treatment modality more efcient,
the addition of Carnoy’s solution has become an
important resource in favor of a considerable
decrease in the recurrence rates of the disease and
exponential improvements in prognoses [17,18].
A mixture of 3ml of chloroform, 6ml of absolute
ethanol, 1ml of acetic acid, and 1g of ferric
chloride composes the so-called Carnoy’s solution,
which acts by promoting a chemical cauterization
of the cystic lesion bed after its enucleation
and curettage, by applying the medication to
the bony defect of the lesion for about three
minutes and subsequent irrigation with saline
solution [18,19]. However, studies have shown
that chloroform, a component of Carnoy’s
solution, is a potential carcinogen. In light of
this, Carnoy’s solution was modied by removing
chloroform from its composition. Nevertheless,
studies have indicated the low efcacy of the
modied Carnoy’s solution. A study conducted
by Dashow et al. [20] compared the effects
of Carnoy’s solution versus modied Carnoy’s
solution and the recurrence of OKC when used
as an adjunct treatment in the enucleation and
simple curettage of OKC. The results showed
that the recurrence rates were significantly
higher in the group of patients who used the
modied Carnoy’s solution (35%) compared to
the Carnoy’s solution (10%). The literature has
shown a new and effective adjunct treatment for
the enucleation and curettage of OKC: the topical
application of 5-uorouracil. This agent is an
antimetabolite frequently used to treat basal cell
carcinoma (BCC). Since the PTCH gene is present
in most cases of OKC, and neoplastic growth
results from PTCH1 mutations that activate the
Smoothened (SMO) and Sonic Hedgehog (SHH)
pathways, it is believed that blocking SMO and
SHH may be effective against the recurrence
of OKC. 5-FU works by inhibiting the enzyme
thymidylate synthase (TS), which inuences DNA
synthesis, leading to cell death. Therefore, 5-FU
could be an alternative to the original Carnoy’s
solution and modied Carnoy’s solution in the
treatment of OKC [21].
Although surgical resection results in a
lower recurrence rate of keratocysts (2%),
therapeutic supplementation with the use of
Carnoy’s solution also allows for a relatively
low recurrence (8%) combined with lower
morbidity and higher quality of life for treated
patients, provided that the solution’s application
time does not exceed ve minutes, which could
cause damage to adjacent nerve and vascular
structures [19,22]. In the present case report, the
initial treatment of the patient did not involve the
use of Carnoy’s solution due to a lack of supplies at